🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted action to address cost of living pressures" in the forthcoming financial statement.

Speaking to media outlets, she emphasized that curbing price rises is a joint task of both the government and the Bank of England.

The UK's price growth is forecast to be the most elevated among the Group of Seven advanced economies this calendar year and next.

Potential Energy Cost Interventions

Reports indicate the government could take action to bring down energy bills, such as by reducing the current 5% level of value-added tax applied on energy supplies.

A further option is to lower some of the government charges currently added to household expenses.

Budgetary Constraints and Expert Predictions

The administration will receive the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for such actions.

The view from the majority of analysts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to meet her self-imposed borrowing rules.

Previously on Thursday, calculations suggested there was a £22 billion gap for the chancellor to address, which is at the more modest range of forecasts.

"There's a shared task between the central bank and the government to further reduce some of the drivers of price increases," the Chancellor told the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Revenue Commitments and Global Issues

While much of the focus has been on probable tax increases, the chancellor said the latest information from the fiscal watchdog had not altered her commitment to manifesto promises not to raise rates on income tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with growing geopolitical and commercial issues for the Budget tax moves, likely to be directed on those "with the broadest shoulders."

Global Economic Tensions

Referring to worries about the United Kingdom's trade ties with China she said: "Our national security always come first."

Last week's announcement by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are crucial for high-technology manufacturing led American leader Donald Trump to suggest an extra 100% import tax on goods from China, increasing the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary described China's decision "commercial pressure" and "a global supply chain control attempt."

Questioned on accepting the American proposal to join its battle with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and encouraged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "damaging for the global economy and generates further challenges."

"It is my opinion there are fields where we need to confront China, but there are also important prospects to trade with Chinese markets, including banking sector and other sectors of the economic system. We've got to get that equilibrium correct."

The Treasury chief also affirmed she was cooperating with international partners "regarding our own essential resources approach, so that we are more independent."

Health Service Medicine Pricing and Investment

The Chancellor also recognized that the price the NHS spends on pharmaceuticals could rise as a result of ongoing negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said in recent statements that they are either halting or canceling operations in the UK, with some blaming the insufficient payments they are receiving.

Recently, the government science advisor said the price the NHS spends on drugs would must rise to prevent firms and drug research funding leaving the UK.

The Chancellor stated to media: "It has been observed because of the pricing regime, that medical research, innovative medicines have not been provided in the United Kingdom in the way that they are in other continental states."

"Our aim is to guarantee that patients receiving treatment from the NHS are able to receive the finest essential medicines in the world. And so we are examining all of that, and... aiming to obtain additional investment into the UK."